相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment
Dipranjan Laha et al.
FRONTIERS IN IMMUNOLOGY (2021)
Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis
Monica E. D'Arcy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Muyue Yang et al.
BIOACTIVE MATERIALS (2021)
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
Mohammad A. I. Al-Hatamleh et al.
JOURNAL OF ONCOLOGY (2019)
Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?
Yuehong Chen et al.
CYTOKINE (2018)
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis A Nationwide Population-Based Cohort Study
Pauline Raaschou et al.
ANNALS OF INTERNAL MEDICINE (2018)
Phage display-derived human antibodies in clinical development and therapy
Andre Frenzel et al.
MABS (2016)
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis
Lucia Silva-Fernandez et al.
RHEUMATOLOGY (2016)
TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection
Ulrike Schleicher et al.
CELL REPORTS (2016)
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Franz Kratochvill et al.
CELL REPORTS (2015)
Systemic use of tumor necrosis factor alpha as an anticancer agent
Nicholas J. Roberts et al.
Oncotarget (2015)
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
Teresa A. Simon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future
Lisa M. Sedger et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Lymphoma development in patients with autoimmune and inflammatory disorders - What are the driving forces?
Eva Baecklund et al.
SEMINARS IN CANCER BIOLOGY (2014)
A Lymphotoxin-β-Specific Receptor
Paul D. Crowe et al.
JOURNAL OF IMMUNOLOGY (2014)
Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies
C. Pouplard et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability
Mohammad Fallahi-Sichani et al.
JOURNAL OF IMMUNOLOGY (2012)
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
Andreas Hess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
Kate A. Markey et al.
BLOOD (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Preclinical Investigation of PEGylated Tumor Necrosis Factor α in Dogs with Spontaneous Tumors: Phase I Evaluation
Douglas H. Thamm et al.
CLINICAL CANCER RESEARCH (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
The role of TNF in parasitic diseases: Still more questions than answers
Heinrich Koerner et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2010)
Tumor Necrosis Factor, Lymphotoxin and Cancer
Marina S. Drutskaya et al.
IUBMB LIFE (2010)
Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety
David Moreno-Ramirez et al.
ONCOLOGIST (2010)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Zehra Kaymakcalan et al.
CLINICAL IMMUNOLOGY (2009)
Cognitive Dysfunction in Mice Deficient for TNF- and Its Receptors
Bernhard T. Baune et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis
Hillarie L. Plessner et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
Emma M. Creagh et al.
TRENDS IN IMMUNOLOGY (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Technology Insight:: utility of TNF-α-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities
DJ Grünhagen et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
J Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
J Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer
S Madhusudan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
TNF pathophysiology in murine models of chronic inflammation and autoimmunity
G Kollias
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: Protective and deleterious effects
SI Grivennikov et al.
IMMUNITY (2005)
Safety overview of new disease-modifying antirheumatic drugs
JJ Cush
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2004)
Lymphoma in rheumatoid arthritis - The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
A phase II study of etanercept (enbrel), a tumor necrosis factor α inhibitor in patients with metastatic breast cancer
S Madhusudan et al.
CLINICAL CANCER RESEARCH (2004)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
The lymphotoxin β receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes
S Ehlers et al.
JOURNAL OF IMMUNOLOGY (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration
SL Brown et al.
ARTHRITIS AND RHEUMATISM (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
JHW de Wilt et al.
BRITISH JOURNAL OF CANCER (2000)
Tumor necrosis factor: a master-regulator of leukocyte movement
JD Sedgwick et al.
IMMUNOLOGY TODAY (2000)
分享论文
